GCTK vs UTHR · P/E 0.1, $4.1M cap vs P/E 20, rev $1.56B
GlucoTrack Inc (GCTK) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
GlucoTrack Inc (GCTK) is a medical instruments & supplies company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
GCTK does not have a complete income-statement cache yet.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
GCTK currently screens at market cap $4.1M and trailing P/E 0.1. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the GCTK and UTHR stock pages for the full models.
Not investment advice.